Axsome Therapeutics, Inc. Investors: Filing date July 12, 2022; Contact the Portnoy Law Firm to Recover Losses


Investors can



contact



the law firm at no cost to learn more about recovering their losses

LOS ANGELES, July 08, 2022 (GLOBE NEWSWIRE) —

The Portnoy Law Firm

advises Axsome Therapeutics, Inc. (“Axsome” or the “Company”) (NASDAQ: AXSM) investors that a class action filed on behalf of investors are encouraged to contact attorney

Lesley F. Portnoy

, by phone 844-767-8529 or

email

: [email protected], to discuss their legal rights, or

click here

to join the case via

www.portnoylaw.com

. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.

On April 25, 2022, Reuters reported that, “Axsome Therapeutics (AXSM) said on Monday it expects the U.S. health regulator to decline approval for its treatment of acute migraine over unresolved issues of its quality control processes, sending shares of the drug developer down 20%.”

On this news, Axsome Inc.’s share price plummeted thereby harming investors.

Please visit our

website

to review more information and submit your transaction information.

The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.

Lesley F. Portnoy, Esq.

Admitted CA and NY Bar


[email protected]


310-692-8883

www.portnoylaw.com

Attorney Advertising


Primary Logo